Correlation Between VIRI Old and Lipocine
Can any of the company-specific risk be diversified away by investing in both VIRI Old and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIRI Old and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIRI Old and Lipocine, you can compare the effects of market volatilities on VIRI Old and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIRI Old with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIRI Old and Lipocine.
Diversification Opportunities for VIRI Old and Lipocine
Poor diversification
The 3 months correlation between VIRI and Lipocine is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding VIRI Old and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and VIRI Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIRI Old are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of VIRI Old i.e., VIRI Old and Lipocine go up and down completely randomly.
Pair Corralation between VIRI Old and Lipocine
If you would invest 274.00 in VIRI Old on November 4, 2024 and sell it today you would earn a total of 0.00 from holding VIRI Old or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 5.0% |
| Values | Daily Returns |
VIRI Old vs. Lipocine
Performance |
| Timeline |
| VIRI Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Lipocine |
VIRI Old and Lipocine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VIRI Old and Lipocine
The main advantage of trading using opposite VIRI Old and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIRI Old position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.| VIRI Old vs. LMF Acquisition Opportunities | VIRI Old vs. ZyVersa Therapeutics | VIRI Old vs. Sonnet Biotherapeutics Holdings | VIRI Old vs. Revelation Biosciences |
| Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |